Healthcare -
Biotechnology - NASDAQ - US
$ 9.78
-1.71 %
$ 135 M
Market Cap
-195.6
P/E
CSBR - REVENUE
Revenue CSBR - Champions Oncology, Inc.
50.2 M
LAST VALUE
1.06%
2 YEAR CAGR
13.13%
5 YEAR CAGR
15.82%
10 YEAR CAGR